October 26, 2020
Mayo Clinic Research in the news — 10/26/2020
At Mayo Clinic, patient care is evidence-based, meaning research drives the practice of medicine. Our scientists and clinician researchers are at work across the spectrum of health and the delivery of health care, seeking better outcomes and enhanced experiences while managing the total costs of care. Curable dementia, pot and opioids, childcare during COVID-19, and […]
Tags: Alzheimer's disease, Andrew Badley, artificial intelligence, autoimmune disorder, biomarkers, cardiovascular medicine, Charles Adler, clinical research, clinical trials, COVID-19, David Knopman, dementia
October 2, 2020
Mayo Clinic Research in the news — 10/2/2020
This week Mayo Clinic Research and researchers have been noted in stories on older women’s sexuality, the opioid crisis, some health benefits of coffee, using Alexa for COVID-19, and a range of other topics. Read on for links and brief excerpts from news outlets around the country. Laughter May Be Effective Medicine for These Trying […]
Tags: Amir Lerman, artificial intelligence, B-cell disorders, biomarkers, C. diff, cancer, cardiology, colon cancer, COVID-19, diabetes, dogs, emergency medicine
August 21, 2020
Mayo Clinic Research in the news — 8/21/2020
A wide range of Mayo Clinic expertise was highlighted in the past week, with local, national and international media outlets quoting researchers and referring to Mayo Clinic research findings. Following are a selection of these news articles, with a brief excerpt and link to the full story on the appropriate websites. For ease of review, […]
Tags: Alzheimer's disease, Andrew Badley, blood pressure, Bobbi Pritt, Brian Mohney, cardiology, Centers for Disease Control and Prevention, COVID-19, diabetes, emergency department, epidemiology, genetics
November 26, 2019
Pursuing the holy grail of flu vaccines
By Advancing the Science contributor
The National Institutes of Health recently established a new research network, Collaborative Influenza Vaccine Innovation Centers (CIVICs), with the collective goal to overcome current problems facing influenza vaccines in order to create long-lasting, broadly protective vaccines. The CIVICs program will include three Vaccine Centers, one Vaccine Manufacturing and Toxicology Core, two Clinical Cores, and one […]
Tags: collaboration, influenza, National Institutes of Health, NIH, Richard Kennedy, vaccines
June 27, 2019
From the desk of a fellow–Zika Virus: A Continuing Focus for Vaccine Development
By Advancing the Science contributor
Stephen Crooke, Ph.D., is a postdoctoral research fellow in the Vaccine Research Group within the Mayo Clinic Department of General Internal Medicine. As a postdoctoral research fellow in the Mayo Clinic Vaccine Research Group, my research is centered primarily around the use of systems biology approaches to develop a more comprehensive understanding of vaccine […]
Tags: Gregory Poland, immunology, infectious disease, Inna Ovsyannikova, Richard Kennedy, Stephen Crooke, vaccines